COVID-19 Update | October 9, 2020

COVID-19 News

COVID-19 Update | October 9, 2020

October 9, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of October 9, 2020. Notable advancements include:

  • Eli Lilly & Co. released new data and said its antibody treatment effectively reduces levels of COVID-19 in patients, keeping them out of emergency rooms and hospitals.
  • Regeneron Pharmaceuticals has submitted an application to the Food and Drug Administration for emergency approval of its experimental COVID-19 antibody treatment.
  • GlaxoSmithKline and Vir Biotechnology, after positive initial results, will expand their trial of an experimental antibody to treat COVID-19. The trial will now expand to 1,300 patients globally.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].